Cold spray could take the sting out of blood gas tests

NCT ID NCT03973385

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 07, 2026 · Last updated Jul 08, 2026 · Updated 1 time

Summary

This trial tests whether a cold spray (cryotherapy) can numb the skin and reduce pain when drawing blood from an artery in intensive care patients. About 200 adults in the ICU who need an arterial blood gas test will receive the spray before the puncture. The study measures pain levels and how easy the procedure is for healthcare workers.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
cryotherapy (vapocoolant spray)
What this could lead to
If effective, this cold spray could offer a simple, drug-free way to reduce pain during a common ICU procedure.
What could go wrong
This is a small, early-stage trial. The cold spray may not significantly reduce pain, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

200 people

The number who actually took part.

Started

Nov 2020

Finished

Jun 2022

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 120 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * All adult patients (age≥18 years) hospitalized in Intensive Care Unit * Patient requiering arteriale puncture for ABG * A négative score of CAM ICU scale * Patient with a score to visual analog scale \< or equal 30mm * Securité sociale affiliated * consentement Exclusion Criteria: * patient undergoing mechanical ventilation * patient with arterial catheter * patient with arterio veinius fistul * patient receiving topical anesthesic at least 2 h before the puncture * patient with cutaneous lesion (zone of puncture) * Raynaud Syndrom * cold sensibility * Allen test negative * pregnant * legal guardianship

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Cryotherapy effect are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CHU Saint LOUIS

    Paris, 75010, France

  • Ch Versailles

    Le Chesnay, 78150, France

  • Hopital Européèn Georges Pompidou

    Paris, 75015, France

  • Hopital Nord Franche-Comte

    Belfort, 90015, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.